Georgetown Breast Cancer Advocates Make Their Case in Cancer Research Journal
Posted in News Release | Tagged advocacy, cancer, cancer research, School of Medicine
WASHINGTON (August 17, 2018) — At Georgetown Lombardi Comprehensive Cancer Center, a group of breast cancer advocates says they’ve created a model for developing productive, successful and sustainable collaborations between advocates and scientists in cancer research. They describe their efforts in an article published online August 17 in the journal Cancer Research.
The Georgetown Breast Cancer Advocates (GBCA), a volunteer group supporting and promoting cancer research at Georgetown University, was formed in 2011. The group has been partly supported through Georgetown Lombardi Comprehensive Cancer Center’s cancer center support grant from the National Cancer Institute (1P30-CA-51008), as well as generous gifts from the Nina Hyde Breast Cancer Research Fund and Women and Wine at Georgetown Lombardi.
Cancer researcher Ayesha Shajahan-Haq, PhD, serves as the group’s scientific adviser.
“The advocates who make up GBCA bring unique and important viewpoints to the cancer research process,” explains Shajahan-Haq, senior author of the article. “As researchers, we need their input to help keep us focused not only on the scientific details of our work, but to keep us grounded and ensure we maintain a patient-centered approach.”
In their article, GBCA address the benefits of engaging advocates in cancer research — both in preclinical and clinical stages — and underscore ways in which both the scientific and advocacy communities can facilitate this mutually beneficial collaboration.
“Their input is not limited to the patient clinical experience,” Shajahan-Haq adds. “Often, they evaluate preclinical research to suggest ways which help make it more relevant to the problem at hand. They are valuable allies in the fight against cancer and integral to the research process.”
The group also outlines ways to cultivate the scientist-advocate relationship long-term, often laying the groundwork with trainee scientists. They also proactively seek out opportunities for advocates to receive training in how to understand and evaluate cancer research, says Jeannine Salamone, part of GBCA and a co-author of the article.
GBCA advocates are often survivors, like Salamone, those living with cancer or those who have had close personal experiences with cancer.
“Due to their familiarity with cancer, advocates want to use their experience to help others facing the disease,” explains GBCA member and co-author Sherri Stahl. “We are strong proponents of scientific progress and are committed to increasing our knowledge and expanding our reach within the community.”
“Many scientists find that collaboration with advocates strengthens their proposals by clarifying their goals and impact on patients,” the article’s authors conclude. “Ultimately, both groups learn more about the other and develop an ongoing relationship characterized by a mutual respect and empathy.”
Additional GBCA members and authors of the article include Wanda Lucas, Shelley Brundage, Jamie N. Holloway, Nora E. Carbine, Margery London, Naomi Greenwood, Rosa Goyes, Deborah Charles Chisholm, Erin Price, Roberta Carlin, Susan Winarsky, Kirsten B. Baker, and Julia Maues.
About Georgetown Lombardi Comprehensive Cancer Center (new window)
Georgetown Lombardi Comprehensive Cancer Center is designated by the National Cancer Institute as a comprehensive cancer center — the only cancer center of its kind in the Washington, D.C. area. A part of Georgetown University Medical Center and MedStar Georgetown University Hospital, Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Connect with Georgetown Lombardi on Facebook (Facebook.com/GeorgetownLombardi (new window)) and Twitter (@LombardiCancer (new window)).
About Georgetown University Medical Center (new window)
Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis — or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health. Connect with GUMC on Facebook (Facebook.com/GUMCUpdate (new window)) and Twitter (@gumedcenter (new window)). Connect with Georgetown University School of Medicine on Facebook (Facebook.com/somgeorgetown (new window)), Twitter (@gumedicine (new window)) and Instagram (@GeorgetownMedicine (new window)).